Position in ALKS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$940,160
+$305,731 QoQ
Shares Held
17,942
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#217
of 421 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Round Rock Advisors LLC holds $3,878,662 across 7 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (24.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
17,942 | $940,160 | |
| 2 | HROW |
Harrow, Inc.
|
17,481 | $742,418 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
8,076 | $668,531 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,226 | $462,102 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
|
10,690 | $386,978 | |
| 6 | XERS |
Xeris Biopharma Holdings, Inc.
|
46,102 | $365,127 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
7,637 | $313,346 |
All Filings in ALKS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $940,160 | 17,942 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $634,429 | 17,942 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $494,014 | 17,656 | Shares | Sole | 2026-04-07 | |
| 2025-09-30 | $497,700 | 16,590 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||